Company overview

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
Founded in 2010
Cambridge, Massachusetts, USA
2.4K employees (105 in marketing)

Salaries

Typical salary range

$224,400 – $294,400

/ yr

Help build salary transparency at BeiGene

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount -9.9% year over year

Funding

Total funding

$6.8B

Last raise

$2.1B

Post IPO Equity, 6 years ago

Funding history

Jul 2020

Post IPO Equity BeiGene · $2.1B

Oct 2019

Post IPO Equity BeiGene · $2.7B

Aug 2018

Post IPO Secondary BeiGene · $903M

Jan 2018

Post IPO Equity BeiGene · $750M

Nov 2016

Post IPO Equity BeiGene · $185M

May 2015

Series B BeiGene · $97M

Audience

Monthly website visitors
39.3K
Month over month-3.1%
Quarter over quarter+2214%
Top sourceReferral (41.7%)
Ad budget per month$37.5K
Average search rank53
Traffic source mix
Referral
41.7%
Search
31.8%
Direct
20.2%
Social
5.2%
Paid referral
1%

LinkedIn followers

Follower count and growth

Total followers

206.7K

12-mo growth

Monthly growth

+0.7%

News

Links